Loading
Watchmaker Genomics
Watchmaker Genomics is a biotechnology company based in Boulder, Colorado, founded in 2019. The company specializes in advanced enzymology, focusing on developing precision tools for next-generation sequencing, molecular diagnostics, and synthetic biology. With a commitment to high-performance protein engineering, Watchmaker Genomics aims to meet the quality and performance demands of clinical genomics applications. The company offers a range of services, including advanced enzyme engineering, large-scale enzyme manufacturing, and custom genomic solutions tailored to specific research needs. Their product portfolio features various enzymes and library preparation kits designed to enhance sequencing workflows and improve data quality. Watchmaker Genomics collaborates with life science companies, commercial sequencing providers, and research labs to advance genomics and synthetic biology applications.
Funding
Every round, secondary, debt facility or acquisition involving Watchmaker Genomics that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
$4M